Walgreens Boots Alliance (NASDAQ:WBA) shares rose more than 3% since the company’s reported Q2 results on Tuesday, with EPS of $1.16 beating the Street estimate of $1.10. Revenue came in at $34.9 billion, better than the Street estimate of $33.53 billion.

The company has made progress in filling pharmacy positions, which management believes will drive script growth in the back half of the year. US Healthcare's momentum continues with the company expanding its value-based and risk arrangements as it focuses on building density and service offerings in specific markets.

The company expects fiscal 2023 EPS to be in the range of $4.45-$4.65, compared to the Street estimate of $4.51.